Upgrades
- Allstate (ALL) upgraded by Keefe Bruyette from Market Perform to Outperform
- Morgan Advanced (MCRUF) upgraded by RBC Capital from Sector Perform to Outperform
- NOV Inc. (NOV) upgraded by Citi from Neutral to Buy
- Norwegian Cruise Line (NCLH) upgraded by UBS from Neutral to Buy
- Fortive (FTV) upgraded by Morgan Stanley from Equal Weight to Overweight
- Bayer (BAYRY) upgraded by Redburn from Neutral to Buy
- Bakkafrost (BKFKF) upgraded by Pareto from Hold to Buy
- Orsted (DNNGY) upgraded by Citi from Sell to Neutral
- Kimberly-Clark (KMB) upgraded by Atlantic Equities from Neutral to Overweight
- Dutch Bros (BROS) upgraded by JPMorgan from Neutral to Overweight
- AIG (AIG) upgraded by Jefferies from Hold to Buy
- Lyft (LYFT) upgraded by Gordon Haskett from Hold to Buy
- CME Group (CME) upgraded by Deutsche Bank from Hold to Buy
- DocuSign (DOCU) upgraded by Wedbush from Underperform to Neutral
Downgrades
Premium Content
- Cooper Companies (COO) downgraded by Jefferies from Buy to Hold
- Verbund (OEZVY) downgraded by Deutsche Bank from Buy to Hold
- Brenntag (BNTGY) downgraded by Barclays from Overweight to Equal Weight
- Smiths Group (SMGZY) downgraded by RBC Capital from Sector Perform to Underperform
- TAG Immobilien (TAGOF) downgraded by Exane BNP Paribas from Outperform to Underperform
- OCI (OCINF) downgraded by Berenberg from Buy to Hold
- Restaurant Group (RSTGF) downgraded by Berenberg from Buy to Hold
- Tullow Oil (TUWOY) downgraded by Jefferies from Buy to Hold
- Pioneer Natural (PXD) downgraded by Citi from Buy to Neutral
- Stanley Black & Decker (SWK) downgraded by Morgan Stanley to Equal Weight
- FIS (FIS) downgraded by Atlantic Equities from Overweight to Neutral
- Fiserv (FISV) downgraded by Atlantic Equities from Overweight to Neutral
- Ryanair (RYAAY) downgraded by Liberum from Buy to Hold
- Hexcel (HXL) downgraded by Truist from Buy to Hold
- Albany International (AIN) downgraded by Truist from Buy to Hold
- ForgeRock (FORG) downgraded by Canaccord from Buy to Hold
- Brooklyn ImmunoTherapeutics (BTX) downgraded by Maxim from Buy to Hold
Motley Fool Stock Advisor's average stock pick is up over 350%*, beating the market by an incredible 4-1 margin. Here’s what you get if you join up with us today: Two new stock recommendations each month. A short list of Best Buys Now. Stocks we feel present the most timely buying opportunity, so you know what to focus on today. There's so much more, including a membership-fee-back guarantee. New members can join today for only $99/year.
Upgrades & Downgrades provided by The Fly at http://www.thefly.com. The Fly is a leading digital publisher of real-time financial news. Our financial market experts understand that news impacting stock prices can originate from anywhere, at any time. The Fly team scours all sources of company news, from mainstream to cutting-edge, then filters out the noise to deliver short-form stories consisting of only market moving content. Become an informed investor. Try all of The Fly’s services FREE for 14 days by clicking here.
Premium Content